The Duke Division of Hematologic Malignancies and Cellular Therapy is internationally recognized for its novel approaches to treating leukemia, lymphoma, myeloma, and other life threatening diseases through integrated, innovative, and holistic patient care, research, and education.
The mission of the division of Hematologic Malignancies and Cellular Therapy is to promote health and improve lives by preventing, diagnosing, and treating blood cancer and other life threatening diseases through integrated, innovative, and holistic patient care, education, and research.
